Skip to content
StockMarketAgent
Sector pending / Pharmaceutical PreparationsUpdated 2026-05-10 22:07 UTC

FRA/0TB stock hub

FRA/0TB has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

FRA/0TBis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
745M
Frankfurt Stock Exchange
Market data

Price

Recent price action with selectable time range.

FRA/0TBFRA/0TB
Loading chart…
In the news

Latest news · FRA/0TB

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 n/aP50 n/aP75 n/a
Trailing P/E7.5
P25 n/aP50 n/aP75 n/a
ROE50.2
P25 n/aP50 n/aP75 n/a
ROIC-3.7
P25 n/aP50 n/aP75 n/a
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All FRA/0TB market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
183
Groups with data
11
Currency
USD
Showing 183 of 183 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

18
MetricValue
Country
Cayman Islands
Country code
DE
Employees
90
Employees Change
-7%
Employees Change Percent
-7.22
Enterprise value
EUR 444.1M
Exchange
Frankfurt Stock Exchange
Financial currency
USD
First seen
2026-05-10
Industry
Pharmaceutical Preparations
Last refreshed
2026-05-10
Market cap
EUR 745M
Price
EUR 14.3
Price currency
EUR
Rev Per Employee
1,057,865.09x
Sic
2834
Symbol
fra/0TB
Website
https://www.theravance.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

10
MetricValue
Earnings Yield
13.33%
EV Earnings
4.47x
EV/EBIT
104.93x
EV/EBITDA
79.49x
EV/FCF
1.91x
EV/Sales
4.76x
FCF yield
31.28%
P/B ratio
2.96x
P/E ratio
7.5x
P/S ratio
7.83x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

18
MetricValue
EBIT Margin
4.54%
EBITDA Margin
5.99%
FCF margin
244.81%
Gross margin
71.04%
Gross Profit
EUR 67.6M
Gross Profit Growth
187.84%
Gross Profit Growth Q
349.67%
Net Income
EUR 99.3M
Net Income Growth3 Y
-49.24%
Pretax Margin
124.72%
Profit Margin
104.34%
Profit Per Employee
EUR 1.1M
ROA
0.76
Roa5y
-11.96
ROCE
1.13
ROE
50.17
ROIC
-3.66
Roic5y
-62.9

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

9
MetricValue
Cagr10y
-0.99%
Cagr1y
62.55%
Cagr3y
12.29%
Cagr5y
-2.22%
EPS Growth3 Y
-43.81
Revenue Growth
68.2x
Revenue Growth Q
15.02x
Revenue Growth3 Y
31.24x
Revenue Growth5 Y
10.63x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

22
MetricValue
Asset Turnover
EUR 0.27
Assets
EUR 409.6M
Cash
EUR 342.3M
Current Assets
EUR 354.1M
Current Liabilities
EUR 26.9M
Debt
EUR 35.1M
Debt EBITDA
EUR 6.16
Debt Equity
EUR 0.14
Debt FCF
EUR 0.15
Equity
EUR 252M
Interest Coverage
2.74
Liabilities
EUR 157.6M
Long Term Assets
EUR 55.5M
Long Term Liabilities
EUR 130.7M
Net Cash
EUR 307.2M
Net Cash By Market Cap
EUR 41.23
Net Cash Growth
341.26%
Net Debt EBITDA
EUR -53.86
Net Debt Equity
EUR -1.22
Net Debt FCF
EUR -1.32
Tangible Book Value
EUR 252M
Tangible Book Value Per Share
EUR 4.89

Liquidity

Current-asset coverage and working-capital efficiency metrics.

5
MetricValue
Current ratio
13.14
Net Working Capital
EUR 1.7M
Quick ratio
12.91
Working Capital
EUR 334.7M
Working Capital Turnover
EUR 0.38

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Buyback Yield
-5.48%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

35
MetricValue
10Y total return
-9.42%
1Y total return
62.5%
200-day SMA
13.58
3Y total return
41.58%
50-day SMA
13.41
50-day SMA vs 200-day SMA
50under200
5Y total return
-10.62%
All Time High
38.3
All Time High Change
-62.66%
All Time High Date
2017-05-10
All Time Low
4.28
All Time Low Change
234.11%
All Time Low Date
2021-09-15
ATR
0.15
Ch YTD
-8.92
High
14.3
High52
17.5
High52 Date
2026-01-23
High52ch
-18.29%
Low
14.3
Low52
7.45
Low52 Date
2025-05-15
Low52ch
91.95%
Ma50ch
6.62%
Price vs 200-day SMA
5.33%
RSI
59.35
RSI Monthly
60.44
RSI Weekly
52.39
Sharpe ratio
1.2x
Sortino ratio
1.98
Total Return
-5.48%
Tr YTD
-8.92
Tr1m
1.42%
Tr1w
1.42%
Tr3m
-11.73%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

2
MetricValue
Operating Income
EUR 4.3M
Operating margin
4.54

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

6
MetricValue
Float
24,547,468%
Shares Insiders
5.7%
Shares Institutions
50.24%
Shares Qo Q
-3.34%
Shares Yo Y
5.48%
Short Ratio
8.53

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

57
MetricValue
Adjusted FCF
EUR 217.4M
Average Volume
0x
Bv Per Share
4.89
CAPEX
EUR -36,427
Ch10y
-9.42
Ch1m
1.42
Ch1w
1.42
Ch1y
62.5
Ch3m
-11.73
Ch3y
41.58
Ch5y
-10.62
Ch6m
11.72
Change
0.7%
Change From Open
0
Close
14.2
Days Gap
0.7
Depreciation Amortization
1,373,274.5
Earnings Date
2026-08-03
EBIT
EUR 4.3M
EBITDA
EUR 5.7M
EPS
EUR 1.92
F Score
7
FCF
EUR 233.1M
FCF EV Yield
52.48x
Financing CF
-6,913,248
Fiscal Year End
December
Founded
2,013
Graham Number
14.40614
Graham Upside
0.74
Income Tax
EUR 19.4M
Investing CF
-72,266,038
Is Primary Listing
0
Last Earnings Date
2026-02-23
Last Report Date
2026-03-31
Lynch Fair Value
EUR 9.53
Lynch Upside
-33.33
Ma150
14.43
Ma150ch
-0.91%
Ma20
14.07
Ma20ch
1.63%
Net CF
153,934,475
Next Earnings Date
2026-08-03
Open
14.3
P FCF Ratio
3.2
P OCF Ratio
3.2
Ppne
24,200,835.5
Price Date
2026-05-08
Price EBITDA
EUR 131
Ptbv Ratio
2.96
Relative Volume
20x
Revenue
95,207,858x
SBC By Revenue
16.49x
Share Based Comp
15,700,732
Tax By Revenue
20.38x
Tax Rate
16.34%
Tr6m
11.72%
Z Score
1.04
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does FRA/0TB pay a dividend?

Capital-return profile for this ticker.

Performance

FRA/0TB stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+62.5%
S&P 500 1Y: n/a
3Y total return
+41.6%
S&P 500 3Y: n/a
5Y total return
-10.6%
S&P 500 5Y: n/a
10Y total return
-9.4%
S&P 500 10Y: n/a
Ownership

Who owns FRA/0TB?

Insider, institutional, and short-interest positioning.

Institutional ownership
+50.2%
Share of float held by funds and institutions
Insider ownership
+5.7%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
8.5 days to cover
Y/Y dilution
+5.5%
Negative means the company is buying back shares.
Technical

FRA/0TB momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
59.3
Neutral momentum band
Price vs 200-day MA
+5.3%
50/200-day relationship not available
Beta (5Y)
n/a
Sensitivity to the broader market
Sharpe ratio
1.20
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About FRA/0TB

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/0TB stock rating?

fra/0TB is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/0TB analysis?

The full report lives at /stocks/fra/0TB/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/0TB?

The latest report frames fra/0TB around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/0TB page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.